| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
2003-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ce1f5338fbedfc7e729c2294f3ca7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3d0326306e42b4d32f90ec0dc3292f |
| publicationDate |
2003-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003191191-A1 |
| titleOfInvention |
Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions |
| abstract |
The present disclosure is directed to methods for alleviating the symptoms associated with peripheral neuropathy by administering R(−)-desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. The neuropathy may be the result of a genetically inherited condition, a systemic disease, or exposure to a toxic agent. The disclosure is also directed to a method for treating patients with cancer by administering a chemotherapeutic agent known to have a toxic affect on peripheral nerves together with R(−)-desmethylselegiline, S(+) desmethylselegiline, or a mixture of the two. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3017818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160053711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102364840-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987322-B1 |
| priorityDate |
1995-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |